Lijun Wen Selected Research

lactotriaosylceramide

7/2012

High expression of lactotriaosylceramide, a differentiation-associated glycosphingolipid, in the bone marrow of acute myeloid leukemia patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lijun Wen Research Topics

Disease

3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 07/2012
3	Neoplasms (Cancer) 12/2021 - 11/2013
3	Leukemia 06/2019 - 09/2014
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2019 - 09/2014
1	Chordoma 01/2022
1	Weight Gain 03/2021
1	Influenza in Birds (Avian Flu) 01/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 12/2019
1	Ischemic Stroke 10/2019
1	Acute Promyelocytic Leukemia 01/2019
1	Infections 01/2018
1	Glioma (Gliomas) 11/2017
1	Chronic Neutrophilic Leukemia 10/2017
1	BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative) 10/2017
1	Pathologic Complete Response 01/2017
1	Eosinophilia 01/2017
1	Parkinson Disease (Parkinson's Disease) 10/2015
1	Hematologic Neoplasms (Hematological Malignancy) 04/2015
1	Blast Crisis (Blast Phase) 09/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2014
1	Body Weight (Weight, Body) 11/2013
1	Hepatocellular Carcinoma (Hepatoma) 11/2013
1	Carcinogenesis 07/2012
1	Alzheimer Disease (Alzheimer's Disease) 11/2011

Drug/Important Bio-Agent (IBA)

2	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2022 - 10/2017
1	TOR Serine-Threonine KinasesIBA 01/2022
1	TensinsIBA 01/2022
1	Class Ia Phosphatidylinositol 3-KinaseIBA 01/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022
1	ClaudinsIBA 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 12/2021
1	NucleotidesIBA 03/2021
1	plectasinIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 12/2019
1	Interleukin-17 ReceptorsIBA 10/2019
1	Long Noncoding RNAIBA 06/2019
1	RetinoidsIBA 01/2019
1	AcidsIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Teniposide (VM 26)FDA Link 11/2017
1	CeramidesIBA 11/2017
1	dihydroceramide desaturaseIBA 11/2017
1	RNA (Ribonucleic Acid)IBA 10/2017
1	Imatinib Mesylate (Gleevec)FDA Link 01/2017
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2017
1	AlkaloidsIBA 01/2016
1	HomoharringtonineIBA 01/2016
1	Neuroprotective AgentsIBA 10/2015
1	schizandrin BIBA 10/2015
1	Transcription Factors (Transcription Factor)IBA 04/2015
1	Carrier Proteins (Binding Protein)IBA 09/2014
1	8- ethoxy- 2- (4- fluorophenyl)- 3- nitro- 2H- chromeneIBA 11/2013
1	TriterpenesIBA 11/2013
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 11/2013
1	lupeolIBA 11/2013
1	lactotriaosylceramideIBA 07/2012
1	GlycosphingolipidsIBA 07/2012
1	Proteins (Proteins, Gene)FDA Link 11/2011
1	Amyloid (Amyloid Fibrils)IBA 11/2011
1	Peptides (Polypeptides)IBA 11/2011

Therapy/Procedure

3	Therapeutics 12/2021 - 11/2013
1	Biological Therapy 01/2022
1	Immunotherapy 12/2021